[ad_1]
WALL In the UK, aspirin will be tested for the treatment of blood clotting caused by Covid-19. In the program called RECOVERY, conducted by the University of Oxford, where possible treatments against the corona virus are studied, the effect of aspirin, which is usually used as an anticoagulant, on the treatment process of the Covid-19 disease will be studied.
In the statement on the RECOVERY website, it was stated that patients infected with the corona virus have a high risk of blood clots due to overactive platelets, and aspirin may reduce the risk of clots. For the trials it was stated that at least 2 thousand patients will be given a daily dose of 150 mg of aspirin and the data obtained from these patients will be compared with patients who receive standard treatment for Covid-19.
“There are clear reasons to believe that aspirin can be useful and is safe, cheap, widely available,” said Peter Horby, principal investigator of the studies that claim that aspirin is ‘safe and cheap’.
Among the treatments tested in the RECOVERY study, is the antibody cocktail developed by Regeneron, which was used in the treatment of United States President Donald Trump, who contracted the coronavirus in October, against Covid-19. (EXTERNAL NEWS)
It might grab your attention
Source link
